Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CETRORELIX
- Effectiveness of Generic Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a Gonadotropin-releasing Hormone（GnRH）Antagonist Protocol in Women Undergoing IVF
- The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders
- Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation Cycles
- Dydrogesterone-Primed Ovarian Stimulation Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in ICSI
- Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures
- Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A
- Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI
- Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.
- Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI
- Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.
- L-carnitine and COH in PCOS Women Undergoing IVF/ICSI Cycles
- Estrogen, Diabetes, and Endothelial Function
- Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response
- Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Patients Undergoing PGT-A
- Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection
- Efficacy of Growth Hormone Supplementation With Gonadotrophins in IVF/ICSI for Poor Responders
- Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVF
- Cetrorelix and Ganirelix Flexible Protocol for (IVF)
- The Impact of Body Weight on Reproductive Outcomes in Poor Ovarian Responders in ICSI Cycles
- Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo Quality
- Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI
- Androgenic Profile Following Controlled Ovarian Stimulation
- Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome
- Random-start Ovarian Stimulation in Egg-donors (ROSE)
- Evaluation of Different Luteal Phase Support Methods in Patients With Poor Ovarian Response
- Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome
- Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSI
- Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response
- Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program
- DHEA Versus Placebo in Women With Poor Ovarian Response
- Ovarian Stimulation With Recombinant Gonadotropins vs. Human Menopausal Gonadotropin in In Vitro Fertilization
- Effect of Cabergoline on Endometrial Vascularity During IntraCytoplasmic Sperm Injection
- Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins
- Clomiphene Citrate in Combination With Gonadotropins for Ovarian Stimulation in Women With Poor Ovarian Response.
- Does Dehydro Epiandrosterone (DHEA) Improve Pregnancy Rate in Women Undergoing IVF/ICSI With Expected Poor Ovarian Response?
- Implantation Enhancement by Elective Cryopreservation of All Viable Embryos
- Administration of DHEA in Patients With Poor Response to Ovarian Stimulation for IVF
- Human Chorionic Gonadotrophin in an Antagonist Protocol
- Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity
- Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression
- Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days
- Reproductive Hormonal Alterations in Obesity
- GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome
- Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)
- Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)
- Lutropin Alfa in Women at Risk of Poor Response
- Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles
- The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors
- Cetrotide Treatment Optimization
- Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH)
- Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid Arthritis
- Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
- Clinical Pharmacological Study of GnRH Antagonist, Cetrorelix for Healthy Female Volunteer
- Effect of Cetrorelex Acetate on Ovarian Function in Women Undergoing Chemotherapy
- GnRH Agonist and Antagonists in an Oocyte Donation Program
- Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
- A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed End
Clinical trials list
click for details